Fifth Third Bancorp’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,214
Closed -$395K 2523
2024
Q1
$395K Buy
1,214
+103
+9% +$25.3K ﹤0.01% 823
2023
Q4
$212K Sell
1,111
-382
-26% -$72.2K ﹤0.01% 959
2023
Q3
$297K Buy
1,493
+39
+3% +$9.22K ﹤0.01% 857
2023
Q2
$415K Sell
1,454
-547
-27% -$152K ﹤0.01% 788
2023
Q1
$434K Buy
2,001
+41
+2% +$7.99K ﹤0.01% 781
2022
Q4
$403K Sell
1,960
-161
-8% -$40.7K ﹤0.01% 760
2022
Q3
$590K Buy
2,121
+37
+2% +$9.41K ﹤0.01% 650
2022
Q2
$398K Buy
2,084
+62
+3% +$10.9K ﹤0.01% 753
2022
Q1
$419K Buy
+2,022
New +$333K ﹤0.01% 774

Other funds holding SWAV

Fifth Third Bancorp's SWAV Position: Q2 2024 in Review

Fifth Third Bancorp sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,214 shares — an estimated $395K sold.

Fifth Third Bancorp first reported a position in SWAV in Q1 2022 and held it in 9 quarters. The position peaked at $590K in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Fifth Third Bancorp reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,214 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $395K.
  • Fifth Third Bancorp first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
  • Fifth Third Bancorp's Shockwave Medical, Inc. Common Stock position peaked at $590K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Fifth Third Bancorp's 13F filing for Q2 2024, filed 22 Jul 2024.